NEWS FEED & ADDITIVE MAGAZINE October 2025 27 Chemlock Nutrition announced the launch of CalBal® [Pro], a next-generation dietary solution that simplifies transition cow management and supports healthier, more productive herds. Building on the proven success of the original Nutricow® CalBal®, the company says that the new CalBal® [Pro] formula is more concentrated, enabling lower feed rates while reducing shipping, storage, and handling costs. Every CalBal® [Pro] pellet is also uniformly blended with Nutrilock® Chromium, leading to improved immune function, better dry matter intake, more energy, more milk production, and more value Chemlock Nutrition remarks. The CalBal® [Pro] is available now throughout the United States. CalBal [Pro] is produced through a vertically integrated, patent-pending process featuring Chemlock’s proprietary CaP Matrix Technology™. This innovation aims to help maintain calcium balance, reduce dyscalcemia, and keep herds performing at their best. “Transition cow health has always been one of the most challenging and costly hurdles for dairy operations,” said Rick Brown, Dairy Science Director at Chemlock Nutrition. “CalBal® [Pro] gives producers a simpler, more reliable way to manage their herds without the burden of urine pH testing, sourcing low-potassium forage, or relying on costly calcium boluses.” Benefits of the product have been explained as: • For Producers: Simplify transition pen care by eliminating urine pH testing, low-k forage and reducing calcium bolus expenses. • For Nutritionists: A consistent, validated solution that reliably reduces dyscalcemia. Read more>> With a multi-year, €10 million investment in research and development (R&D), Hendrix Genetics is accelerating the genetic engine of its turkey breeding program. This investment is an additional commitment beyond the company’s existing R&D budget, reinforcing its dedication to innovation and long-term progress in animal genetics. As a strategic initiative, it marks a significant milestone in Hendrix Genetics’ efforts to deliver year-over-year improvements in turkey genetics, marketed globally under the Hybrid Turkeys brand, according to the company’s statement. The investment will focus on three pillars of the genetic progress: Increasing selection intensity, improving the accuracy of breeding values, and expanding genetic variation. “As the turkey market demands shift and challenges intensify, staying ahead requires continuous innovation,” says Andrew Hunt, Managing Director for the turkeys business unit. Hendrix Genetics highlights its commitment to advancing critical traits such as feed efficiency, body weight, breast meat and livability – all of which directly impact customer profitability and the sustainability of the value chain. Read more>> New dyscalcemia solution targets transition cow performance Hendrix Genetics invests €10m for turkey breeding program Photo: Freepik Photo: Freepik
RkJQdWJsaXNoZXIy MTUxNjkxNQ==